Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 10:11:1089714.
doi: 10.3389/fchem.2023.1089714. eCollection 2023.

Mining the Protein Data Bank to inspire fragment library design

Affiliations

Mining the Protein Data Bank to inspire fragment library design

Julia Revillo Imbernon et al. Front Chem. .

Abstract

The fragment approach has emerged as a method of choice for drug design, as it allows difficult therapeutic targets to be addressed. Success lies in the choice of the screened chemical library and the biophysical screening method, and also in the quality of the selected fragment and structural information used to develop a drug-like ligand. It has recently been proposed that promiscuous compounds, i.e., those that bind to several proteins, present an advantage for the fragment approach because they are likely to give frequent hits in screening. In this study, we searched the Protein Data Bank for fragments with multiple binding modes and targeting different sites. We identified 203 fragments represented by 90 scaffolds, some of which are not or hardly present in commercial fragment libraries. By contrast to other available fragment libraries, the studied set is enriched in fragments with a marked three-dimensional character (download at 10.5281/zenodo.7554649).

Keywords: FBDD; PDB; binding mode; interaction graph; scaffold; similarity; site comparison.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Overall workflow.
FIGURE 2
FIGURE 2
Properties of the versatile PDB fragments. (A) Molecular weight vs. AlogP (B) Number of rings (C) PBF vs. Number of rotatable bonds (D) Number of binding modes vs. Number of binding cavities. The distributions of individual properties are given on the top and side of the heat maps in (A), (C) and (D). The color scale on the side of the heat maps in (A), (C) and (D) refers to the number of fragments.
FIGURE 3
FIGURE 3
Examples of three-dimensional structures of PDB versatile fragments (A) Interactions formed by pyrrolo-pyrimidine in tRNA-guanine transglycolase and nitryl reductase QueF. (B) Substituted furanone binding to two adjacent subpockets in strigolactone esterase D14. The cavity points representing the two subpockets and used for the comparison of the two sites are shown in the left image.
FIGURE 4
FIGURE 4
Representative chemical structures of the versatile PDB fragments which are absent or poorly represented in commercial fragments libraries. Below each fragment structure are indicated the HET code, then the number of binding modes/the number of different cavities/the number of versatile PDB fragments containing the same scaffold/the number of commercial fragments containing the same scaffold.
FIGURE 5
FIGURE 5
Spatial distribution of the fragments in GTM Landscapes (A) Versatile PDB fragments (B) All commercially-available fragments (C) Ensemble of nature-product like commercial libraries. (D) Examples of versatile PDB fragments. Their projection points are marked with blue dots on the map (A). Figures 5B, C are adapted from (Revillo Imbernon et al., 2022).

Similar articles

Cited by

References

    1. Baell J. B., Holloway G. A. (2010). New substructure filters for removal of Pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53, 2719–2740. 10.1021/jm901137j - DOI - PubMed
    1. Bajusz D., Wade W. S., Satała G., Bojarski A. J., Ilaš J., Ebner J., et al. (2021). Exploring protein hotspots by optimized fragment pharmacophores. Nat. Commun. 12, 3201. 10.1038/s41467-021-23443-y - DOI - PMC - PubMed
    1. Barelier S., Sterling T., O’Meara M. J., Shoichet B. K. (2015). The recognition of identical ligands by unrelated proteins. ACS Chem. Biol. 10, 2772–2784. 10.1021/acschembio.5b00683 - DOI - PMC - PubMed
    1. Bemis G. W., Murcko M. A. (1996). The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 39, 2887–2893. 10.1021/jm9602928 - DOI - PubMed
    1. Berman H. M., Westbrook J., Feng Z., Gilliland G., Bhat T. N., Weissig H., et al. (2000). The protein Data Bank. Nucleic Acids Res. 28, 235–242. 10.1093/nar/28.1.235 - DOI - PMC - PubMed

LinkOut - more resources